中文 | English
Return
Total: 93 , 1/10
Show Home Prev Next End page: GO
Author:(Yanling XIAO)

1.lnterleukin-18 inhibits experimental choroidal neovascularization and its potential therapeutic applications

Yanling XIAO ; Yuyu WU

Chinese Journal of Ocular Fundus Diseases 2016;32(4):457-459

2.The analyzing to the effects of high-order scattered X-ray to dose calculation in radiotherapy

Yanling BAI ; Xuefu XIAO ; Wencheng SHAO

Chinese Journal of Radiation Oncology 2012;21(4):384-387

3.Investigation of 8 MV X-rays energy spectrum structure of medical linear accelerator

Yanling BAI ; Xuefu XIAO ; Wencheng SHAO

Chinese Journal of Radiation Oncology 2012;21(2):181-184

4.Biothermo-kinetic comparative study on Taohua anti-diarrhea decoction prepared by two different ways

Yanling ZHAO ; Weijun KONG ; Xiaohe XIAO

Academic Journal of Second Military Medical University 2000;0(11):-

5.Effect of Qingxin Yangshen Chinese herbs on ?-adrenoceptor in cardiocytes of stress rats

Yanling XIAO ; Shuran MA ; Qiang LIU

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(05):-

6.Biothermodynamic characteristics of Radix Isatis by microcalorimetry

Yanling ZHAO ; Jiabo WANG ; Xiaohe XIAO

Chinese Traditional and Herbal Drugs 1994;0(02):-

8.Smashing Tissue Extraction and GC Analysis of Active Fatty Acids from Oil Cake of Perilla Seeds

Yanling SUN ; Yanze LIU ; Han XIAO ; Yingfeng WEI ; Yuqing ZHAO

Chinese Herbal Medicines 2011;03(1):75-78

9.Cloning and expression of the key enzyme hyoscyamine 6 beta-hydroxylase gene (DaH6H) in scopolamine biosynthesis of Datura arborea.

Wei QIANG ; Yanling HOU ; Xiao LI ; Ke XIA ; Zhihua LIAO

Acta Pharmaceutica Sinica 2015;50(10):1346-55

10.Relationship of apoptosis, proliferation, p53, and Fas with clinicopathological characteristics in human hepatocellular carcinoma

Yanling ZHANG ; Houjie LIANG ; Wenhua XIAO ; Xiaoch YAN

Journal of Third Military Medical University 2003;0(24):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 93 , 1/10 Show Home Prev Next End page: GO